These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 15485615)

  • 21. Tumor markers: the potential of "omics" approach.
    Sikaroodi M; Galachiantz Y; Baranova A
    Curr Mol Med; 2010 Mar; 10(2):249-57. PubMed ID: 20196723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Complementary Role of Imaging and Tumor Biomarkers in Gynecological Cancers: An Update of the Literature.
    Anastasi E; Gigli S; Ballesio L; Angeloni A; Manganaro L
    Asian Pac J Cancer Prev; 2018 Feb; 19(2):309-317. PubMed ID: 29479951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum proteomic profiling reveals potential biomarkers for cutaneous malignant melanoma.
    Solassol J; Du-Thanh A; Maudelonde T; Guillot B
    Int J Biol Markers; 2011; 26(2):82-7. PubMed ID: 21607923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simultaneous and exact interval estimates for the contrast of two groups based on an extremely high dimensional variable: application to mass spec data.
    Park Y; Downing SR; Kim D; Hahn WC; Li C; Kantoff PW; Wei LJ
    Bioinformatics; 2007 Jun; 23(12):1451-8. PubMed ID: 17459967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of biomarkers from mass spectrometry data using a "common" peak approach.
    Fushiki T; Fujisawa H; Eguchi S
    BMC Bioinformatics; 2006 Jul; 7():358. PubMed ID: 16869977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent advances in computational analysis of mass spectrometry for proteomic profiling.
    Sun CS; Markey MK
    J Mass Spectrom; 2011 May; 46(5):443-56. PubMed ID: 21500303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of proteomics in cancer gene profiling: two-dimensional difference in gel electrophoresis (2D-DIGE).
    Hariharan D; Weeks ME; Crnogorac-Jurcevic T
    Methods Mol Biol; 2010; 576():197-211. PubMed ID: 19882264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Global proteomics profiling improves drug sensitivity prediction: results from a multi-omics, pan-cancer modeling approach.
    Ali M; Khan SA; Wennerberg K; Aittokallio T
    Bioinformatics; 2018 Apr; 34(8):1353-1362. PubMed ID: 29186355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tissue and serum proteomic profiling for diagnostic and prognostic bladder cancer biomarkers.
    Schwamborn K; Gaisa NT; Henkel C
    Expert Rev Proteomics; 2010 Dec; 7(6):897-906. PubMed ID: 21142890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic and therapeutic advances in gynecologic oncology: screening for gynecologic cancer.
    Kim YB; Ghosh K; Ainbinder S; Berek JS
    Cancer Treat Res; 1998; 95():253-76. PubMed ID: 9619288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical proteomics in cancer: Where we are.
    Panis C; Pizzatti L; Souza GF; Abdelhay E
    Cancer Lett; 2016 Nov; 382(2):231-239. PubMed ID: 27561426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer proteomics: developments in technology, clinical use and commercialization.
    Yeat NC; Lin C; Sager M; Lin J
    Expert Rev Proteomics; 2015 Aug; 12(4):391-405. PubMed ID: 26145529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer proteomics.
    Tan HT; Lee YH; Chung MC
    Mass Spectrom Rev; 2012; 31(5):583-605. PubMed ID: 22422534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proteomics in clinical laboratory diagnosis.
    Shoshan SH; Admon A
    Adv Clin Chem; 2005; 39():159-84. PubMed ID: 16013671
    [No Abstract]   [Full Text] [Related]  

  • 35. Proteomics of breast carcinoma.
    Somiari RI; Somiari S; Russell S; Shriver CD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 815(1-2):215-25. PubMed ID: 15652811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proteomic approach to breast cancer.
    Laronga C; Drake RR
    Cancer Control; 2007 Oct; 14(4):360-8. PubMed ID: 17914336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proteomic strategies and challenges in tumor metastasis research.
    Hudler P; Gorsic M; Komel R
    Clin Exp Metastasis; 2010 Aug; 27(6):441-51. PubMed ID: 20607365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Feature selection and nearest centroid classification for protein mass spectrometry.
    Levner I
    BMC Bioinformatics; 2005 Mar; 6():68. PubMed ID: 15788095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential predictive plasma biomarkers for cervical cancer by 2D-DIGE proteomics and Ingenuity Pathway Analysis.
    Guo X; Hao Y; Kamilijiang M; Hasimu A; Yuan J; Wu G; Reyimu H; Kadeer N; Abudula A
    Tumour Biol; 2015 Mar; 36(3):1711-20. PubMed ID: 25427637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-throughput proteomics and AI for cancer biomarker discovery.
    Xiao Q; Zhang F; Xu L; Yue L; Kon OL; Zhu Y; Guo T
    Adv Drug Deliv Rev; 2021 Sep; 176():113844. PubMed ID: 34182017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.